Holding the Line: Inside the Ongoing Battle Between Pet Food Advocates and the FDA Over Transparency and Enforcement

By Investigative Journalism Desk
Published: September 2026

Main Facts: The Accountability Gap in American Pet Food Regulation

For millions of pet owners, commercial pet food is trusted implicitly as a safe, regulated, and truthfully marketed product. However, behind the glossy packaging, ingredient lists, and regulatory seals lies a deepening crisis of oversight. Advocacy groups, spearheaded by platforms like TruthaboutPetFood.com, are sounding the alarm over what they characterize as systematic regulatory failure, chronic non-responsiveness, and an outright refusal by the U.S. Food and Drug Administration (FDA) to enforce existing federal laws governing pet food labeling and safety.

At the core of the issue is a widening chasm between the statutory mandates laid out in the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the day-to-day realities of pet food enforcement. Under the FD&C Act, the FDA’s Center for Veterinary Medicine (CVM) is charged with ensuring that all animal foods—much like human foods—are safe to eat, manufactured under sanitary conditions, free of harmful substances, and truthfully labeled.

Yet, routine inquiries and formal petitions submitted by consumer advocates reveal a troubling pattern: the agency charged with policing the industry appears increasingly opaque, dismissive of public inquiries, and reluctant to challenge misleading commercial practices. From deceptive product imagery and vague definitions of slaughterhouse waste products to glaring information gaps regarding avian flu risks in dry kibble, the FDA’s silence has left pet owners navigating a regulatory blind spot.

Chronology of Communications: A Timeline of Agency Silence

To understand the scope of the FDA’s detachment from consumer concerns, one need only examine the paper trail of unanswered correspondence. Over the past several years, consumer advocate Susan Thixton and the Association for Truth in Pet Food have repeatedly attempted to engage federal regulators on critical transparency issues, only to be met with dead air, circular bureaucratic responses, or outright stonewalling.

January 2026 – September 2026: The Meow Mix Labeling Inquiry

• January 28, 2026: Advocates formally contacted the FDA regarding the packaging of Meow Mix Original Choice cat food. The product’s label prominently features high-appeal, fresh-food imagery: a grilled chicken breast, a roasted turkey piece, and two whole fish fillets. However, the actual ingredient list reveals processed meal derivatives—specifically chicken by-product meal, turkey by-product meal, salmon meal, and ocean fish meal. Pointing to the FD&C Act’s requirement for truthful labeling, advocates asked the FDA to explain how this marketing aligns with federal law.
• March 12, 2026: Having received zero acknowledgment, advocates sent a formal follow-up to the CVM, demanding either a substantive response or an explanation for the agency’s refusal to answer.
• September 15, 2026: To date, the FDA has provided no explanation whatsoever regarding how the Meow Mix label complies with federal truth-in-advertising standards.

July 2026: The "Tankage" Transparency Question

• July 6, 2026: Advocates pressed the FDA for clarification on how commonly used, highly processed slaughterhouse by-products are identified for consumers. Specifically, they inquired about "tankage"—a term used to describe condemned materials processed in USDA slaughter facilities. The core question: If tankage originates from a USDA chicken slaughter facility, how is it legally required to be disclosed on a pet food label? Is it broadly termed "chicken," or accurately designated as "chicken meal"?
• Current Status: The FDA failed to provide any response or clarification.

May 2025 – June 2026: The AAFCO Modernization Disconnect

• May 29, 2025: Following the FDA’s decision to end its long-standing relationship and Memorandum of Understanding (MOU) with the Association of American Feed Control Officials (AAFCO), advocates sought clarity on regulatory continuity. They specifically asked whether upcoming AAFCO Pet Food Label Modernization updates would still be recognized and implemented by the FDA.
• Early June 2025: The FDA’s AskCVM department responded within a week, but instead of answering the question, they simply provided a link to a generic stakeholder letter acknowledging the expiring MOU.
• June 5, 2025 (and subsequent follow-ups): Pointing out that the provided link contained zero information regarding label modernization, advocates reiterated their direct question: Will the label changes be implemented or not?
• Outcome: The FDA issued a brief, dismissive follow-up telling advocates to "refer to our previous response"—effectively dodging a straightforward regulatory question.

September 2025: Avian Flu Risk Disclosures

• September 15, 2025: Advocates raised urgent safety questions regarding the FDA’s public communications strategy surrounding Highly Pathogenic Avian Influenza (HPAI). While the FDA issued repeated, prominent safety warnings cautioning consumers against raw pet foods due to HPAI contamination risks, government statistics indicated that raw-fed pets accounted for a tiny fraction (only 4%) of total diagnosed domestic cat cases (145 total cases recorded since May 2022).
• The Core Inquiry: Advocates demanded to know what style of food the remaining 96% of diagnosed cats consumed, what percentage were indoor-only, and what percentage had outdoor access. They challenged the agency: If 96% of cases involved outdoor access or, conversely, consumed commercial kibble, wasn’t the FDA acting negligently by withholding this vital context and focusing exclusively on raw diets?
• Outcome: The FDA offered no answers, leaving pet owners without complete epidemiological data to properly assess risks.

2022 – 2026: The Citizen Petition Saga

• July 2022: Facing rampant misleading marketing, advocates filed an official Citizen Petition with the FDA, citing numerous violations of federal law concerning deceptive pet food ingredient names and demanding corrective regulatory action.
• The Wait: Although federal guidelines dictate that the FDA should respond to Citizen Petitions within 180 days, the agency dragged its feet for an astonishing 1,333 days. When the formal response finally arrived, the answer was a definitive "no"—the agency refused to enforce the law as requested.
• April 13, 2026: Refusing to accept the dismissal, advocates filed a formal Petition for Reconsideration, supplying fresh, concrete evidence that consumers are being actively deceived due to regulatory laxity, and requested a decision within a mandatory 45-day window.
• September 15, 2026: Over 155 days have passed since the reconsideration request, and the FDA has yet to issue a response.

Supporting Data: Examining the Regulatory Disconnect

To fully grasp the gravity of the standoff between consumer advocates and the federal government, one must examine the quantitative metrics underpinning the pet food landscape and regulatory sluggishness.

• 1,333 Days: The protracted delay required for the FDA to formally respond to the 2022 Citizen Petition on misleading labeling—nearly seven times longer than the statutory 180-day guideline.
• 4% vs. 96%: The statistical disparity in HPAI (avian flu) diagnostics among domestic cats. While the FDA’s public safety campaigns have zeroed in on raw pet food (accounting for just 4% of diagnosed cases), the agency has maintained total silence regarding the dietary and lifestyle profiles of the remaining 96% of infected felines.
• 155+ Days: The elapsed time since advocates filed their April 2026 Petition for Reconsideration—a window in which the FDA has missed its own self-imposed or expected operational timelines.
• Zero Responses: The total number of substantive answers provided by the CVM regarding specific front-of-package marketing discrepancies (such as the Meow Mix fresh-meat imagery versus processed meal reality) over multiple formal inquiries.

Official Responses: A Culture of Bureaucratic Deflection

When federal oversight bodies are designed to protect public health and consumer interests, communication channels are meant to serve as a bridge between industry accountability and the public trust. However, the documented interactions between the FDA’s Center for Veterinary Medicine and pet food safety advocates highlight a systemic breakdown in institutional responsiveness.

The official correspondence from the FDA primarily falls into two categories: total silence or procedural deflection. When asked straightforward regulatory questions—such as how slaughterhouse "tankage" must be disclosed on commercial labels, or whether AAFCO’s modernized labeling standards will be enforced post-MOU—the CVM has repeatedly defaulted to avoidance.

In the case of the AAFCO modernization inquiry, the agency’s response was emblematic of modern bureaucratic evasion: pointing stakeholders to generic archival pages that lacked any answers, followed by a blunt refusal to elaborate ("We would refer you to our previous response"). Similarly, on complex, high-stakes epidemiological issues like avian flu vectors in domestic animals, the agency has chosen the path of selective disclosure, releasing partial warnings while withholding broader contextual data that could challenge or nuance their preferred public narratives.

Implications: What This Means for Pet Owners and the Industry

The FDA’s persistent failure to engage with consumer advocates, answer basic labeling questions, or enforce foundational statutes carries profound implications for the multi-billion-dollar pet food industry and the tens of millions of households that rely on it.

1. The Erosion of Truth in Labeling

When federal regulators permit manufacturers to display glossy, high-resolution images of fresh cuts of chicken, turkey, and fish on packages whose actual contents are derived entirely from low-grade meal by-products, it creates an environment of legalized deception. Consumers are paying premium prices under the visual assumption that they are feeding their pets whole, high-quality ingredients, only to find that federal oversight bodies view such marketing practices as acceptable, or at least unworthy of enforcement action.

2. Compromised Public Health and Safety

Public health communication must be comprehensive to be effective. By hyper-focusing public alerts on raw diets while ignoring or failing to transparently report the dietary backgrounds of the vast majority of HPAI-diagnosed cats (the 96%), the FDA risks steering pet owners away from one potential risk while leaving them entirely blind to others. True preventive health policy requires total data transparency, not selective alarmism.

3. The Collapse of Regulatory Accountability

Perhaps the most damaging implication is the message sent to the pet food manufacturing sector. When an oversight agency takes nearly four years to answer a fundamental Citizen Petition—ultimately declining to enforce existing law—and ignores ongoing inquiries regarding ingredient transparency, it signals to industry players that compliance is largely optional.

Moving Forward

Despite institutional roadblocks, bureaucratic stonewalling, and months of silence, consumer advocates vow to maintain the pressure. Organizations like the Association for Truth in Pet Food continue to push for transparency at every regulatory level, reminding the federal government that accountability is not optional. For pet owners across the nation, this ongoing battle serves as a stark reminder: until federal regulators step up to enforce the law, consumer vigilance remains the first—and often the only—line of defense.